Consistent with the enhanced tumor suppression, immunophenotyping of both tumors from mice receiving different treatments demonstrated that mice treated with KYNase and Dox formulated in the hydrogel elicited significantly more CD8+ and CD4+ TILs (Fig. 5d, e). The gene discussed is CD4; the disease is neoplasm.